GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Angelalign Technology 6699.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

79.25

+0.25%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Net income

$12.1m

FY2018FY2024

Free cash flow

−$11.4m

FY2018FY2024

Shareholders' equity

$474.1m

FY2018FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross profit$168.2m$130.7m$109.9m$826.6m$575.0m$417.1m$311.7m
Research and development$20.4m$23.8m$19.9m$120.5m$89.5m$76.2m$48.6m
Operating income−$402,000−$2.6m$24.6m$304.4m$195.1m$84.3m$77.0m
Net income$12.1m$7.5m$29.9m$285.8m$150.7m$68.8m$59.8m
Diluted earnings per share0.070.040.181.790.910.420.36

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$678.1m$671.6m$618.9m$579.1m$166.9m$852.8m$472.5m
Cash and short-term investments$436.8m$485.6m$503.5m$507.2m$121.1m$504.7m$216.0m
Total liabilities$204.0m$200.5m$121.3m$114.9m$97.7m$555.4m$306.0m
Debt$14.5m$9.2m$3.9m$4.2m$2.8m$29.2m$23.0m
Shareholders' equity$474.1m$471.1m$497.6m$464.1m$69.2m$297.4m$166.5m
Shares outstanding169m169m169m160m166m166m166m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations$16.9m$22.3m$20.5m$60.9m$56.3m$402.3m$144.6m
Capital spending−$28.3m−$15.7m−$13.3m−$27.6m−$5.7m−$99.7m−$45.0m
Free cash flow−$11.4m$6.5m$7.2m$33.4m$50.6m$302.6m$99.6m
Dividends paid−$23.8m−$14.8m−$24.6m−$13.7m———

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Gross profit$100.6m$93.7m$75.7m$77.9m$365.7m$454.3m$331.4m$449.0m
Operating income$18.1m$3.2m$533,000$3.9m−$44.5m$134.8m$50.0m$189.4m
Net income$14.6m$9.0m$3.2m$2.9m$32.3m$139.5m$74.3m$189.7m
Diluted earnings per share0.090.050.020.020.190.830.441.12
Total assets—$678.1m$712.4m$671.6m$646.9m$618.9m$4.23bn$4.14bn
Cash and short-term investments—$436.8m$484.1m$485.6m$487.6m$503.5m$3.52bn$3.63bn
Debt—$7.4m$6.4m$5.2m$2.9m$2.0m$10.9m$15.5m
Shareholders' equity—$474.1m$452.0m$471.1m$463.4m$497.6m$3.35bn$3.32bn

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin61.8%62.6%62.4%61.9%65.0%70.4%
Operating margin6.3%-0.1%4.7%20.0%26.2%23.6%
Net margin7.7%4.5%3.6%16.8%22.5%18.5%
Return on equity5.7%2.6%1.6%5.9%8.6%30.0%
Return on assets3.7%1.8%1.1%4.8%6.9%12.5%
Free cash flow yield6.9%1.7%2.2%1.9%5.0%4.0%
Revenue growth32.2%32.9%16.2%-0.2%55.7%26.4%
Earnings growth125.2%65.3%-75.0%-25.2%89.7%118.9%
Current ratio2.98x3.84x4.23x4.95x5.34x1.49x
Debt to equity0.01x0.00x0.01x0.00x0.01x0.03x
Equity ratio65.3%69.9%70.2%80.4%80.2%41.5%
Interest coverage13.46x-1.90x8.62x151.21x270.99x166.71x
R&D as a share of sales7.3%7.9%11.8%11.6%9.7%11.4%
Buybacks as a share of market value-0.8%-0.4%0.3%-0.2%-14.9%11.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-40.4%-16.1%—
Net income-65.1%-29.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin62.5%64.1%65.7%—
Operating margin-0.6%16.9%17.9%—
Net margin4.1%17.4%16.4%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings105.2162.288.917.8
Price to sales4.75.815.04.0

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 21 May 2026.

FY2025FY2024FY2023FY2022
Paid in the year0.842.200.681.22

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.